Men1 disruption in Nkx3.1-deficient mice results in ARlow/CD44+ microinvasive carcinoma development with the dysregulated AR pathway - Archive ouverte HAL Access content directly
Journal Articles Oncogene Year : 2021

Men1 disruption in Nkx3.1-deficient mice results in ARlow/CD44+ microinvasive carcinoma development with the dysregulated AR pathway

(1) , (1) , (1) , (1) , (2) , (2) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1)
1
2
Not file

Dates and versions

hal-03666659 , version 1 (12-05-2022)

Identifiers

Cite

Romain Teinturier, Yakun Luo, Myriam Decaussin-Petrucci, Virginie Vlaeminck-Guillem, Francis Vacherot, et al.. Men1 disruption in Nkx3.1-deficient mice results in ARlow/CD44+ microinvasive carcinoma development with the dysregulated AR pathway. Oncogene, 2021, 40 (6), pp.1118-1127. ⟨10.1038/s41388-020-01589-1⟩. ⟨hal-03666659⟩
6 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More